1. Home
  2. TRVI vs BELFB Comparison

TRVI vs BELFB Comparison

Compare TRVI & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • BELFB
  • Stock Information
  • Founded
  • TRVI 2011
  • BELFB 1949
  • Country
  • TRVI United States
  • BELFB United States
  • Employees
  • TRVI N/A
  • BELFB N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • BELFB
  • Sector
  • TRVI Health Care
  • BELFB
  • Exchange
  • TRVI Nasdaq
  • BELFB Nasdaq
  • Market Cap
  • TRVI 725.7M
  • BELFB 865.9M
  • IPO Year
  • TRVI 2019
  • BELFB N/A
  • Fundamental
  • Price
  • TRVI $7.01
  • BELFB $143.88
  • Analyst Decision
  • TRVI Strong Buy
  • BELFB Strong Buy
  • Analyst Count
  • TRVI 10
  • BELFB 4
  • Target Price
  • TRVI $19.35
  • BELFB $129.75
  • AVG Volume (30 Days)
  • TRVI 2.0M
  • BELFB 137.8K
  • Earning Date
  • TRVI 11-05-2025
  • BELFB 10-22-2025
  • Dividend Yield
  • TRVI N/A
  • BELFB 0.19%
  • EPS Growth
  • TRVI N/A
  • BELFB N/A
  • EPS
  • TRVI N/A
  • BELFB 4.05
  • Revenue
  • TRVI N/A
  • BELFB $594,034,000.00
  • Revenue This Year
  • TRVI N/A
  • BELFB $25.48
  • Revenue Next Year
  • TRVI N/A
  • BELFB $5.57
  • P/E Ratio
  • TRVI N/A
  • BELFB $34.62
  • Revenue Growth
  • TRVI N/A
  • BELFB 6.08
  • 52 Week Low
  • TRVI $2.36
  • BELFB $58.00
  • 52 Week High
  • TRVI $8.78
  • BELFB $145.79
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 44.05
  • BELFB 70.12
  • Support Level
  • TRVI $7.09
  • BELFB $130.13
  • Resistance Level
  • TRVI $8.78
  • BELFB $141.80
  • Average True Range (ATR)
  • TRVI 0.43
  • BELFB 4.33
  • MACD
  • TRVI -0.07
  • BELFB -0.14
  • Stochastic Oscillator
  • TRVI 4.32
  • BELFB 91.06

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

Share on Social Networks: